Skip to main content
padlock icon - secure page this page is secure

The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013

Buy Article:

$39.00 + tax (Refund Policy)

Importance:

It is important to understand the magnitude and distribution of the economic burden of prescription opioid overdose, abuse, and dependence to inform clinical practice, research, and other decision makers. Decision makers choosing approaches to address this epidemic need cost information to evaluate the cost effectiveness of their choices.

Objective:

To estimate the economic burden of prescription opioid overdose, abuse, and dependence from a societal perspective.

Design, Setting, and Participants:

Incidence of fatal prescription opioid overdose from the National Vital Statistics System, prevalence of abuse and dependence from the National Survey of Drug Use and Health. Fatal data are for the US population, nonfatal data are a nationally representative sample of the US civilian noninstitutionalized population ages 12 and older. Cost data are from various sources including health care claims data from the Truven Health MarketScan Research Databases, and cost of fatal cases from the WISQARS (Web-based Injury Statistics Query and Reporting System) cost module. Criminal justice costs were derived from the Justice Expenditure and Employment Extracts published by the Department of Justice. Estimates of lost productivity were based on a previously published study.

Exposure:

Calendar year 2013.

Main Outcomes and Measures:

Monetized burden of fatal overdose and abuse and dependence of prescription opioids.

Results:

The total economic burden is estimated to be $78.5 billion. Over one third of this amount is due to increased health care and substance abuse treatment costs ($28.9 billion). Approximately one quarter of the cost is borne by the public sector in health care, substance abuse treatment, and criminal justice costs.

Conclusions and Relevance:

These estimates can assist decision makers in understanding the magnitude of adverse health outcomes associated with prescription opioid use such as overdose, abuse, and dependence.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: abuse and dependence; economic burden; overdose; prescription opioid

Document Type: Original Article

Affiliations: National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA

Publication date: 01 October 2016

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more